Skip to main content

Table 1 Clinical characteristics of ten patients with Coronavirus 19 severe acute respiratory distress syndrome

From: Rescue therapy with inhaled nitric oxide and almitrine in COVID-19 patients with severe acute respiratory distress syndrome

Variables  
Age (years) 60 (52–72)
Female gender 3 (30%)
Body mass index (kg/m2) 28.2 (22.0–37.4)
Comorbidities
 Dyslipidemia 2 (20%)
 Current smoker 2 (20%)
 Arterial hypertension 5 (50%)
 Diabetes mellitus 5 (50%)
 Atrial fibrillation 0
 Heart failure 0
 Previous stroke 0
 COPD 1 (10%)
 Cirrhosis 0
 Dialysis 1 (10%)
 Previous stroke 0
Standard treatments  
 Anticoagulant 0
 Antiplatelet therapy 0
 ACE inhibitors or ARB 5 (50%)
Organ failure at admission
 Charlson comorbidity index 2 (0–2)
 SAPS-II 36 (32–46)
 SOFA score 6 (3–7)
 PaO2/FiO2 112 (92–144)
 Neuromuscular-blocking agent use 7 (70%)
 Shock 1 (10%)
  1. Values are expressed as median (interquartile range)
  2. C-ARDS COVID-19 ARDS patients, ARDS: acute respiratory distress syndrome, COPD chronic obstructive pulmonary disease, ACE angiotensin-converting enzyme, ARB angiotensin receptors blockers, SAPS II Simplified Acute Physiology Score II, SOFA score Sequential Organ Failure Assessment, PaO2 arterial oxygen tension, FiO2 fraction of inspired oxygen